[1] LEVY M M,FINK M P,MARSHALL J C,et al.2001 SCCM /ESICM /AC-CP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31(4):1250-1256.
[2] DELLINGER R P,LEVY M M,CARLET J M.et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Crit Care Med,2008,36(1):296-327.
[3] 王鸣,彭炜,蔡敏,等.外科重症监护室645例脓毒症患者临床流行病学调查[J].中国危重病急救医学,2006,18(2):74-77.
[4] ENGEL C,BRUNKHORST F M,BONE H G,et al.Epidemiology of sepsis in Germany:results from a national prospective multicenter study[J].Intensive Care Med,2007,33(4):606-618.
[5] FINFER S,BELLOMO R,LIPMAN J,et al.Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units[J].Intensive Care Med,2004,30(4):589-596.
[6] PADKIN A,GOLDFRAD C,BRADY A R,et al.Epidemiology of severe sepsis occurring in the first 24 hours in ICU in England,Wales and Northern Ireland[J].Crit Care Med,2003,31(9):2332-2338.
[7] STPHANE H,SAX H,PHILIPPE E A,et al.Nosocomial Bloodstream infection and clinical sepsis[J].Emerg infect dis,2004,10(1):76-81.
[8] NGUYEN H B,CORBETT S W,STEELE R,et al.Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality[J].Crit Care Med,2007,35(4):1105-1112.
[9] 严静,刘大为.降低严重感染与感染性休克的病死率:机遇与挑战并[J].中国危重病急救医学,2007,19(3):插页.
[10] CARTER C.Implementing the severe sepsis care bundles outside the ICU by outreach[J].Nurs Crit Care,2007,12(5):225-230.
[11] RIVERS E,NGUYEN B,HAVSTAD S.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Engl N Med,2001,345:1368-1377.
[12] 严静.严重脓毒症早期目标指导性治疗:亟待规范[J].中国实用外科杂志,2009,29(12):974-975.
[13] 纪国业,王斌,杜江,等.不同时间血液灌流对脓毒症兔血IL-6及TNF-α的影响[J].现代医学,2011,39(2):129-133.
[14] 李国民,吴晶,袁冬,等.去甲肾上腺素联合左西蒙旦或多巴酚丁胺对脓毒性休克猪的影响[J].东南大学学报:医学版,2011,30(6):892-895.
[15] 戴林峰,王醒.脓毒症与凝血功能异常[J].东南大学学报:医学版,2012,31(3):359-362.
[16] 陈齐红,郑瑞强,林华,等.感染性休克集束治疗对病死率影响的前瞻性研究[J].中国危重病急救医学,2008,20(9):534-537.
[17] 郭琦,黎敏毅,农凌波,等.严重感染集束治疗的依从性研究[J].中国危重病急救医学,2009,21(1):8-12. |